Levonorgestrel Lupin Healthcare (Uk)

Levonorgestrel, the active ingredient in Levonorgestrel Lupin Healthcare (Uk), is a Progestin presented as an unknown/unknown for Oral use. It is used for emergency contraception and regular hormonal contraception to prevent pregnancy. GNH USA supplies Levonorgestrel Lupin Healthcare (Uk) as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levonorgestrel is a synthetic progestogen used in hormonal contraceptive pathways. It provides the following clinical benefits: - Emergency contraception: prevents pregnancy after unprotected intercourse when taken within the recommended time frame. - Regular contraception: offers ongoing prevention of pregnancy when used as a scheduled hormonal method. - Ovulation suppression: inhibits the release of an egg, reducing the chance of fertilisation.

Levonorgestrel may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Headache: occasional tension‑type headache. - Abdominal pain: cramping or discomfort in the lower abdomen. - Fatigue: feeling unusually tired. - Breast tenderness: mild swelling or sensitivity. - Menstrual changes: spotting or altered flow.

Serious or Rare Side Effects: - Thromboembolic events: blood clots in veins or arteries. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Liver dysfunction: jaundice or abnormal liver enzymes. - Ectopic pregnancy: implantation outside the uterus. - Persistent abdominal pain: could indicate a serious condition. - Severe vaginal bleeding: unexpected heavy bleeding.

Before using Levonorgestrel, consider the following safety measures: - Assess medical history: evaluate for clotting disorders, cardiovascular disease, liver impairment, or hormone‑sensitive cancers. - Review current medications: check for drugs that may reduce effectiveness, such as enzyme‑inducing anticonvulsants. - Pregnancy testing: ensure the patient is not already pregnant before administration. - Breastfeeding guidance: discuss potential effects with a healthcare professional. - Follow‑up: advise patients to seek medical attention if they experience severe abdominal pain, unusual bleeding, or signs of a blood clot. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture and direct sunlight.

Levonorgestrel can interact with several medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin): may markedly reduce contraceptive effectiveness. - Rifampicin or rifabutin: can lower plasma concentrations, increasing risk of unintended pregnancy. - St. John’s wort: herbal inducer that may diminish hormonal activity.

Moderate Interactions (Monitor Closely): - Azole antifungals (e.g., ketoconazole, itraconazole): may increase levonorgestrel levels, raising side‑effect risk. - Macrolide antibiotics (e.g., erythromycin, clarithromycin): can modestly elevate hormone concentrations. - Other hormonal therapies (e.g., estrogen‑containing products): may have additive effects on clotting risk.